vs
Side-by-side financial comparison of Lifeway Foods, Inc. (LWAY) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
Lifeway Foods, Inc. is the larger business by last-quarter revenue ($55.4M vs $39.6M, roughly 1.4× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 4.6%, a 31.3% gap on every dollar of revenue. On growth, Lifeway Foods, Inc. posted the faster year-over-year revenue change (18.0% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $-17.4M). Over the past eight quarters, Lifeway Foods, Inc.'s revenue compounded faster (11.4% CAGR vs -15.0%).
Lifeway Foods is an Illinois-based health food company founded in 1986. They are a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
LWAY vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.4M | $39.6M |
| Net Profit | $2.5M | $14.2M |
| Gross Margin | 27.8% | 73.1% |
| Operating Margin | 6.8% | 32.5% |
| Net Margin | 4.6% | 35.9% |
| Revenue YoY | 18.0% | -10.9% |
| Net Profit YoY | 1688.1% | 117.2% |
| EPS (diluted) | $0.15 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $55.4M | $39.6M | ||
| Q3 25 | $57.1M | $43.4M | ||
| Q2 25 | $53.9M | $43.4M | ||
| Q1 25 | $46.1M | $47.3M | ||
| Q4 24 | $46.9M | $44.4M | ||
| Q3 24 | $46.1M | $53.1M | ||
| Q2 24 | $49.2M | $53.1M | ||
| Q1 24 | $44.6M | $54.8M |
| Q4 25 | $2.5M | $14.2M | ||
| Q3 25 | $3.5M | $12.8M | ||
| Q2 25 | $4.2M | $2.5M | ||
| Q1 25 | $3.5M | $21.5M | ||
| Q4 24 | $-160.0K | $6.5M | ||
| Q3 24 | $3.0M | $2.8M | ||
| Q2 24 | $3.8M | $18.5M | ||
| Q1 24 | $2.4M | $18.8M |
| Q4 25 | 27.8% | 73.1% | ||
| Q3 25 | 28.7% | 70.6% | ||
| Q2 25 | 28.6% | 69.2% | ||
| Q1 25 | 23.9% | 79.7% | ||
| Q4 24 | 25.3% | 76.3% | ||
| Q3 24 | 25.7% | 81.5% | ||
| Q2 24 | 27.0% | 74.2% | ||
| Q1 24 | 25.8% | 72.1% |
| Q4 25 | 6.8% | 32.5% | ||
| Q3 25 | 8.8% | 36.6% | ||
| Q2 25 | 10.8% | 33.6% | ||
| Q1 25 | 3.4% | 51.1% | ||
| Q4 24 | 1.5% | 10.6% | ||
| Q3 24 | 9.1% | 26.1% | ||
| Q2 24 | 11.0% | 51.4% | ||
| Q1 24 | 8.0% | 44.6% |
| Q4 25 | 4.6% | 35.9% | ||
| Q3 25 | 6.2% | 29.6% | ||
| Q2 25 | 7.9% | 5.7% | ||
| Q1 25 | 7.7% | 45.4% | ||
| Q4 24 | -0.3% | 14.7% | ||
| Q3 24 | 6.5% | 5.3% | ||
| Q2 24 | 7.7% | 34.8% | ||
| Q1 24 | 5.4% | 34.2% |
| Q4 25 | $0.15 | $0.15 | ||
| Q3 25 | $0.23 | $0.12 | ||
| Q2 25 | $0.28 | $0.02 | ||
| Q1 25 | $0.23 | $0.21 | ||
| Q4 24 | $0.00 | $0.05 | ||
| Q3 24 | $0.19 | $0.03 | ||
| Q2 24 | $0.25 | $0.20 | ||
| Q1 24 | $0.16 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.6M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $85.8M | $248.3M |
| Total Assets | $105.6M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | $164.1M | ||
| Q3 25 | $23.0M | $127.4M | ||
| Q2 25 | $21.2M | $152.7M | ||
| Q1 25 | $19.4M | $132.1M | ||
| Q4 24 | $16.7M | $125.0M | ||
| Q3 24 | $20.6M | $137.4M | ||
| Q2 24 | $14.6M | — | ||
| Q1 24 | $12.0M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.5M | — |
| Q4 25 | $85.8M | $248.3M | ||
| Q3 25 | $82.8M | $248.0M | ||
| Q2 25 | $78.7M | $244.6M | ||
| Q1 25 | $74.2M | $226.4M | ||
| Q4 24 | $71.9M | $195.1M | ||
| Q3 24 | $71.5M | $205.0M | ||
| Q2 24 | $68.0M | $8.8M | ||
| Q1 24 | $63.5M | $9.0M |
| Q4 25 | $105.6M | $380.4M | ||
| Q3 25 | $109.5M | $321.4M | ||
| Q2 25 | $98.3M | $315.3M | ||
| Q1 25 | $93.7M | $284.6M | ||
| Q4 24 | $90.5M | $266.1M | ||
| Q3 24 | $91.3M | $296.5M | ||
| Q2 24 | $84.9M | $19.5M | ||
| Q1 24 | $82.8M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $267.0K | $52.0M |
| Free Cash FlowOCF − Capex | $-17.4M | $51.2M |
| FCF MarginFCF / Revenue | -31.5% | 129.3% |
| Capex IntensityCapex / Revenue | 31.9% | 2.0% |
| Cash ConversionOCF / Net Profit | 0.11× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.4M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $267.0K | $52.0M | ||
| Q3 25 | $6.9M | $-20.9M | ||
| Q2 25 | $3.9M | $-8.3M | ||
| Q1 25 | $-150.0K | $1.9M | ||
| Q4 24 | $-2.6M | $-7.3M | ||
| Q3 24 | $7.5M | $5.0M | ||
| Q2 24 | $6.5M | $19.2M | ||
| Q1 24 | $1.5M | $3.7M |
| Q4 25 | $-17.4M | $51.2M | ||
| Q3 25 | $1.8M | $-20.9M | ||
| Q2 25 | $1.6M | $-8.6M | ||
| Q1 25 | $-2.4M | $1.7M | ||
| Q4 24 | $-3.8M | $-7.9M | ||
| Q3 24 | $5.9M | $4.6M | ||
| Q2 24 | $5.1M | $18.3M | ||
| Q1 24 | $-923.0K | $3.0M |
| Q4 25 | -31.5% | 129.3% | ||
| Q3 25 | 3.1% | -48.3% | ||
| Q2 25 | 3.0% | -19.9% | ||
| Q1 25 | -5.1% | 3.5% | ||
| Q4 24 | -8.2% | -17.8% | ||
| Q3 24 | 12.8% | 8.7% | ||
| Q2 24 | 10.4% | 34.5% | ||
| Q1 24 | -2.1% | 5.4% |
| Q4 25 | 31.9% | 2.0% | ||
| Q3 25 | 9.0% | 0.1% | ||
| Q2 25 | 4.3% | 0.7% | ||
| Q1 25 | 4.8% | 0.5% | ||
| Q4 24 | 2.7% | 1.3% | ||
| Q3 24 | 3.3% | 0.8% | ||
| Q2 24 | 2.9% | 1.6% | ||
| Q1 24 | 5.5% | 1.3% |
| Q4 25 | 0.11× | 3.66× | ||
| Q3 25 | 1.96× | -1.63× | ||
| Q2 25 | 0.92× | -3.39× | ||
| Q1 25 | -0.04× | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | 2.50× | 1.77× | ||
| Q2 24 | 1.73× | 1.04× | ||
| Q1 24 | 0.64× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LWAY
| Drinkable Kefirotherthan Pro Bugs | $47.8M | 86% |
| Cheese | $4.7M | 8% |
| Cream And Other | $1.7M | 3% |
| Other | $1.2M | 2% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
